DekaBank Deutsche Girozentrale - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 16.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$178,000
-18.7%
49,6000.0%0.00%
-100.0%
Q2 2021$219,000
+31.1%
49,6000.0%0.00%0.0%
Q1 2021$167,000
-2.9%
49,6000.0%0.00%0.0%
Q4 2020$172,000
+55.0%
49,6000.0%0.00%
Q3 2020$111,000
+19.4%
49,600
-2.7%
0.00%
-100.0%
Q3 2019$93,000
-62.8%
51,000
-50.0%
0.00%0.0%
Q2 2019$250,000
+20.8%
102,000
+63.2%
0.00%0.0%
Q1 2019$207,000
+81.6%
62,500
+22.5%
0.00%0.0%
Q4 2018$114,000
-44.9%
51,000
-18.4%
0.00%0.0%
Q3 2018$207,000
+16.3%
62,5000.0%0.00%0.0%
Q2 2018$178,000
-23.3%
62,5000.0%0.00%
-50.0%
Q1 2018$232,000
+146.8%
62,500
+35.9%
0.00%
+100.0%
Q1 2016$94,000
-11.3%
46,000
-1.9%
0.00%0.0%
Q4 2014$106,000
+6.0%
46,900
-8.8%
0.00%0.0%
Q3 2014$100,000
-45.4%
51,400
+2.0%
0.00%
-66.7%
Q2 2014$183,000
-13.3%
50,400
-7.4%
0.00%0.0%
Q1 2014$211,000
+56.3%
54,400
+9.0%
0.00%
+50.0%
Q4 2013$135,000
-22.9%
49,900
+2.0%
0.00%
-33.3%
Q3 2013$175,00048,9000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders